Novel Psychoactive Substances Policy, Economics and Drug Regulation
In light of the recent emergence of New Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the
- PDF / 2,955,402 Bytes
- 192 Pages / 439.43 x 683.15 pts Page_size
- 44 Downloads / 186 Views
ovel Psychoactive Substances Policy, Economics and Drug Regulation
Novel Psychoactive Substances
Ornella Corazza • Andres Roman-Urrestarazu Editors
Novel Psychoactive Substances Policy, Economics and Drug Regulation
Editors Ornella Corazza School of Life and Medical Sciences University of Hertfordshire Hatfield, UK
Andres Roman-Urrestarazu Institute of Public Health University of Cambridge Cambridge, UK
ISBN 978-3-319-60599-9 ISBN 978-3-319-60600-2 DOI 10.1007/978-3-319-60600-2
(eBook)
Library of Congress Control Number: 2017947704 © Springer International Publishing AG 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
This book is dedicated to all those who fear the change: see the opportunity and face the challenge
Foreword
Illicitly used synthetic drugs present a distinctive challenge to international drug control efforts. Unlike drugs such as heroin and cocaine, which are derived from plants and for which the sources may be geographically constrained, synthetic drugs can be manufactured anywhere. At the 53rd session of the United Nations Commission on Narcotic Drugs (CND) in 2010, the international community noted in CND resolution 53/11 entitled Promoting the sharing of information on the potential abuse of and trafficking in synthetic cannabinoid receptor agonist the increasing reports of the production of substances, most commonly herbal mixtures, containing synthetic cannabinoid receptor agonists (SCRAs) with psychoactive effects similar to those produced by cannabis. Within 2 years, CND resolution 55/1 (2012) entitled Promoting international cooperation in responding to the challenges posed by new psychoactive substan
Data Loading...
